Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
British Journal of Pharmacology|March 7, 1998
Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissuesA P Davenport, R E Kuc, M J Ashby, et al.Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Synthesis of novel substituted pyridines as inhibitors of endothelin converting enzyme-1 (ECE-1)M A Massa, W C Patt, K Ahn, et al.The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeysM J Ryan, G W Hicks, B L Batley, et al.Journal of Medicinal Chemistry|March 6, 1992
Perfluorocarbon-based antidiabetic agentsK L Kees, T M Smith, M L McCaleb, et al.Journal of Cardiovascular Pharmacology|January 1, 1995
Structure-activity relationships of a novel series of orally active nonpeptide ETA and ETA/B endothelin receptor-selective antagonistsA M Doherty, W C Patt, J Repine, et al.Journal of Medicinal Chemistry|July 20, 1992
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitorsW C Patt, H W Hamilton, M D Taylor, et al.Journal of Medicinal Chemistry|March 1, 1991
N6-substituted adenosine receptor agonists: potential antihypertensive agentsB K Trivedi, C J Blankley, J A Bristol, et al.Journal of Medicinal Chemistry|March 1, 1986
Ribose-modified adenosine analogues as adenosine receptor agonistsM D Taylor, W H Moos, H W Hamilton, et al.Journal of Medicinal Chemistry|June 23, 1999
Butenolide endothelin antagonists with improved aqueous solubilityW C Patt, X M Cheng, J T Repine, et al.Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.Pageof 1